Sensorion SA Logo

Sensorion SA (ALSEN)

Euronext

Currency in EUR
0.2780
+0.0060 (+2.21%)

Closed

Aug 25, 2026

Day's Range

0.2650
0.2800

52 wk Range

0.2220
0.8080

Overview - ALSEN - Sensorion SA

Key Statistics

Valuation

Enterprise Value

95.32M

P/E (Trailing)

‪-2.69‬

P/E (Forward)

‪-5.86‬

PEG Ratio

‪-5.86‬

Price / Sales (TTM)

‪23.40‬

Price / Book

‪1.78‬

EV / EBITDA

‪-3.20‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪-399.79%‬

Return on Assets

‪-26.12%‬

Return on Equity

‪-50.47%‬

Ownership

Shares Outstanding

300.34M

Float

300.40M

Held by Insiders

‪34.76%‬

Held by Institutions

‪35.52%‬

Price stats

Beta

‪0.41‬

50-Day Avg

‪0.2663‬

200-Day Avg

‪0.3443‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Buy

5 analysts

Average price target

‪€ 1.14‬

Market Cap - ALSEN - Sensorion SA

Peers - ALSEN - Sensorion SA

Peer Comparison

Compared with companies in Biotechnology listed on Euronext.

Profile Summary - ALSEN - Sensorion SA

About

Sensorion SA is a biopharmaceutical company dedicated to the development of innovative therapies for inner ear disorders. Known for its cutting-edge research in otoplatform technology, Sensorion aims to address conditions like sudden sensorineural hearing loss, tinnitus, and balance disorders. The company's primary…

SectorHealthcare
IndustryBiotechnology
Employees63
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.